211 related articles for article (PubMed ID: 37556385)
21. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
[TBL] [Abstract][Full Text] [Related]
22. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
[TBL] [Abstract][Full Text] [Related]
23. Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice.
Wozniak KM; Nomoto K; Lapidus RG; Wu Y; Carozzi V; Cavaletti G; Hayakawa K; Hosokawa S; Towle MJ; Littlefield BA; Slusher BS
Cancer Res; 2011 Jun; 71(11):3952-62. PubMed ID: 21498637
[TBL] [Abstract][Full Text] [Related]
24. Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy.
Chen YF; Wu CH; Chen LH; Lee HW; Lee JC; Yeh TK; Chang JY; Chou MC; Wu HL; Lai YP; Song JS; Yeh KC; Chen CT; Lee CJ; Shia KS; Shen MR
J Med Chem; 2022 Mar; 65(6):4767-4782. PubMed ID: 35234475
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Tonello R; Lee SH; Berta T
J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
[TBL] [Abstract][Full Text] [Related]
26. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat.
Cavaletti G; Cavalletti E; Montaguti P; Oggioni N; De Negri O; Tredici G
Neurotoxicology; 1997; 18(1):137-45. PubMed ID: 9215996
[TBL] [Abstract][Full Text] [Related]
27. Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.
Zheng H; Xiao WH; Bennett GJ
Exp Neurol; 2011 Dec; 232(2):154-61. PubMed ID: 21907196
[TBL] [Abstract][Full Text] [Related]
28. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
29. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.
Chen Y; Yang C; Wang ZJ
Neuroscience; 2011 Oct; 193():440-51. PubMed ID: 21763756
[TBL] [Abstract][Full Text] [Related]
30. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
Jin HY; Lee NY; Ko HA; Lee KA; Park TS
Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
Carozzi VA; Canta A; Chiorazzi A
Neurosci Lett; 2015 Jun; 596():90-107. PubMed ID: 25459280
[TBL] [Abstract][Full Text] [Related]
32. Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration.
Yang IH; Siddique R; Hosmane S; Thakor N; Höke A
Exp Neurol; 2009 Jul; 218(1):124-8. PubMed ID: 19409381
[TBL] [Abstract][Full Text] [Related]
33. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
[TBL] [Abstract][Full Text] [Related]
34. Impact of drug formulations on kinetics and toxicity in a preclinical model of paclitaxel-induced neuropathy.
Klein I; Wiesen MHJ; Albert V; Bobylev I; Joshi AR; Müller C; Lehmann HC
J Peripher Nerv Syst; 2021 Jun; 26(2):216-226. PubMed ID: 33683765
[TBL] [Abstract][Full Text] [Related]
35. Electroacupuncture Alleviates Paclitaxel-Induced Peripheral Neuropathic Pain in Rats via Suppressing TLR4 Signaling and TRPV1 Upregulation in Sensory Neurons.
Li Y; Yin C; Li X; Liu B; Wang J; Zheng X; Shao X; Liang Y; Du J; Fang J; Liu B
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775332
[TBL] [Abstract][Full Text] [Related]
36. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
37. Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.
Chen YF; Chen LH; Yeh YM; Wu PY; Chen YF; Chang LY; Chang JY; Shen MR
Sci Rep; 2017 Mar; 7():45366. PubMed ID: 28349969
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of Mitochondrial Human Carbonic Anhydrases VA and VB as a Therapeutic Strategy against Paclitaxel-Induced Neuropathic Pain in Mice.
Micheli L; Testai L; Angeli A; Carrino D; Pacini A; Margiotta F; Flori L; Supuran CT; Calderone V; Ghelardini C; Di Cesare Mannelli L
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682907
[TBL] [Abstract][Full Text] [Related]
39. Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain.
Sisignano M; Angioni C; Park CK; Meyer Dos Santos S; Jordan H; Kuzikov M; Liu D; Zinn S; Hohman SW; Schreiber Y; Zimmer B; Schmidt M; Lu R; Suo J; Zhang DD; Schäfer SM; Hofmann M; Yekkirala AS; de Bruin N; Parnham MJ; Woolf CJ; Ji RR; Scholich K; Geisslinger G
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12544-12549. PubMed ID: 27791151
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
